PrEP is protective against HIV infection across populations, presents few significant safety risks, and there is no evidence of behavioral risk compensation. The effective and cost-effective use of PrEP will require development of best practices for fostering uptake and adherence among people at substantial HIV risk.
Authors: Fonner, V.A., Dalglish, S.L., Kennedy, C.E., Baggaley, R., O'Reilly, K.R., Koechlin, F.M., et al.
Download file(s)
Publishing organization